Invega Sustenna Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Alerts
• Clinical Trials
• Forums

A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA ® in Schizophrenia Patients
Conditions:   Schizo Affective Disorder;   Schizophrenia;   Schizoaffective Disorder Interventions:   Drug: LY03010;   Drug: Invega Sustenna 156 MG in 1 ML Prefilled Syringe Sponsor:   Luye Pharma Group Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2018 Category: Research Source Type: clinical trials

A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare Facilities
Condition:   Schizophrenia Interventions:   Drug: Risperidone 3 mg;   Drug: Paliperidone Palmitate 50 mg eq.;   Drug: Paliperidone Palmitate 75 mg eq.;   Drug: Paliperidone Palmitate 100 mg eq.;   Drug: Paliperidone Palmitate 150 mg eq.;   Drug: Paliperidone Palmitate 175 mg eq.;   Drug: Paliperidone Pa lmitate 263 mg eq.;   Drug: Paliperidone Palmitate 350 mg eq.;   Drug: Paliperidone Palmitate 525 mg eq. Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 22, 2018 Category: Research Source Type: clinical trials